Actualités Ramm Pharma Corp - RAMM | Actions Canadian Securities Exchange

Votre Hub pour des idées et discussions en direct en temps réel

Premium

RAMM Pharma Commences Epifractán™ Sales through Peruvian Pharmacies and Scales up Exports to Brazil

TORONTO, Oct. 08, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Announces Approval and Registration of Epifractán™ 2% by Peru’s Ministry of Health

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Announces Approval and Registration of Epifractán™ 5% by Peru’s Ministry of Health and Enters Distribution A...

TORONTO, July 09, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma announces its quarter financial results for Q2 2020

TORONTO, June 29, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

TORONTO, April 15, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution

TORONTO, March 26, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Corp. Provides Details on Operational Activities to Support COVID-19 Medical Response Effort & Corporate Update

TORONTO, March 23, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Corp. to Acquire NettaLife, a Leading Developer of Cannabis-Based Products for Pets and Large Animals

TORONTO, Feb. 25, 2020 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Corp. Welcomes Legalization of Medical Cannabis in Brazil

TORONTO, Dec. 05, 2019 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Corp. Commences Trading on the Canadian Securities Exchange Under Ticker Symbol “RAMM” and Provides Corporate...

TORONTO, Nov. 08, 2019 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the...

RAMM Pharma Corp. (formerly MTC Growth Fund-I Inc.) Announces Closing of Business Combination with RAMM Pharma Holdings Corp....

TORONTO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (the “Company” or "RAMM"), formerly MTC Growth...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ramm Pharma Corp (RAMM)

Votre Hub pour des idées et discussions en direct en temps réel

RAMM Actualités

RAMM Pharma Commences Epifractán™ Sales through Peruvian Pharmacies and Scales up Exports to Brazil

RAMM Pharma Announces Approval and Registration of Epifractán™ 2% by Peru’s Ministry of Health

RAMM Pharma Announces Approval and Registration of Epifractán™ 5% by Peru’s Ministry of Health and Enters Distribution A...

RAMM Pharma announces its quarter financial results for Q2 2020

RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements

RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution

RAMM Pharma Corp. Provides Details on Operational Activities to Support COVID-19 Medical Response Effort & Corporate Update

RAMM Pharma Corp. to Acquire NettaLife, a Leading Developer of Cannabis-Based Products for Pets and Large Animals

RAMM Pharma Corp. Welcomes Legalization of Medical Cannabis in Brazil

RAMM Pharma Corp. Commences Trading on the Canadian Securities Exchange Under Ticker Symbol “RAMM” and Provides Corporate...

RAMM Pharma Corp. (formerly MTC Growth Fund-I Inc.) Announces Closing of Business Combination with RAMM Pharma Holdings Corp....

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ramm Pharma Corp (RAMM) Actualités

Ramm Pharma Corp (RAMM)

Votre Hub pour des idées et discussions en direct en temps réel

RAMM Actualités

RAMM Pharma Commences Epifractán™ Sales through Peruvian Pharmacies and Scales up Exports to Brazil

RAMM Pharma Announces Approval and Registration of Epifractán™ 2% by Peru’s Ministry of Health

RAMM Pharma Announces Approval and Registration of Epifractán™ 5% by Peru’s Ministry of Health and Enters Distribution A...

RAMM Pharma announces its quarter financial results for Q2 2020

RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements

RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX™ 10 (cannabidiol) Oral Solution

RAMM Pharma Corp. Provides Details on Operational Activities to Support COVID-19 Medical Response Effort & Corporate Update

RAMM Pharma Corp. to Acquire NettaLife, a Leading Developer of Cannabis-Based Products for Pets and Large Animals

RAMM Pharma Corp. Welcomes Legalization of Medical Cannabis in Brazil

RAMM Pharma Corp. Commences Trading on the Canadian Securities Exchange Under Ticker Symbol “RAMM” and Provides Corporate...

RAMM Pharma Corp. (formerly MTC Growth Fund-I Inc.) Announces Closing of Business Combination with RAMM Pharma Holdings Corp....

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application